cis-MartynosideCAS# 155899-92-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 155899-92-6 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C31H40O15 | M.Wt | 652.6 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
cis-Martynoside Dilution Calculator
cis-Martynoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.5323 mL | 7.6617 mL | 15.3233 mL | 30.6466 mL | 38.3083 mL |
5 mM | 0.3065 mL | 1.5323 mL | 3.0647 mL | 6.1293 mL | 7.6617 mL |
10 mM | 0.1532 mL | 0.7662 mL | 1.5323 mL | 3.0647 mL | 3.8308 mL |
50 mM | 0.0306 mL | 0.1532 mL | 0.3065 mL | 0.6129 mL | 0.7662 mL |
100 mM | 0.0153 mL | 0.0766 mL | 0.1532 mL | 0.3065 mL | 0.3831 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Mahanimbilol
Catalog No.:BCN9365
CAS No.:77156-13-9
- Pseudocolumbamine
Catalog No.:BCN9364
CAS No.:64191-04-4
- (7R,8R)-Dihydrodehydrodiconiferyl alcohol 9-O-β-D-glucoside
Catalog No.:BCN9363
CAS No.:351346-10-6
- Ethyl brevifolincarboxylate
Catalog No.:BCN9362
CAS No.:107646-82-2
- Ethyl (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate
Catalog No.:BCN9361
CAS No.:947529-92-2
- 6,6'-Di-O-sinapoylsucrose
Catalog No.:BCN9360
CAS No.:1068661-35-7
- Betulinic acid palmitate
Catalog No.:BCN9359
CAS No.:19833-15-9
- Juncusol 2-O-glucoside
Catalog No.:BCN9358
CAS No.:175094-14-1
- Convallagenin B
Catalog No.:BCN9357
CAS No.:17934-59-7
- 3-Hydroxyperillaldehyde
Catalog No.:BCN9356
CAS No.:1932348-11-2
- Methyl lucidenate A
Catalog No.:BCN9355
CAS No.:105742-79-8
- 1-[2-Hydroxy-4-(hydroxymethyl)phenyl]ethanone
Catalog No.:BCN9354
CAS No.:22518-00-9
- N-Phenethylcinnamamide
Catalog No.:BCN9367
CAS No.:103188-43-8
- Nandazurine
Catalog No.:BCN9368
CAS No.:49679-20-1
- Gnetifolin E
Catalog No.:BCN9369
CAS No.:140671-07-4
- (-)-Phaselic acid
Catalog No.:BCN9370
CAS No.:423170-79-0
- 16,25-Di-O-acetylcucurbitacin F
Catalog No.:BCN9371
CAS No.:2062685-10-1
- Hemslecin D
Catalog No.:BCN9372
CAS No.:586960-44-3
- (6R,9S)-3-Oxo-α-ionol glucoside
Catalog No.:BCN9373
CAS No.:159813-37-3
- 2',6'-Dihydroxy-4'-methoxy-3'-methylacetophenone
Catalog No.:BCN9374
CAS No.:69480-06-4
- Juncusol 7-O-glucoside
Catalog No.:BCN9375
CAS No.:175094-15-2
- (6R,9R)-3-Oxo-α-ionol glucoside
Catalog No.:BCN9376
CAS No.:77699-19-5
- 1,7-Bis(4-hydroxyphenyl)-5-hydroxyhept-1-en-3-one
Catalog No.:BCN9377
CAS No.:1426059-89-3
- 7α-Methoxy-5α,6α-epoxyergosta-8(14),22-dien-3β-ol
Catalog No.:BCN9378
CAS No.:1207441-49-3
Bioactive constituents of Lindernia crustacea and its anti-EBV effect via Rta expression inhibition in the viral lytic cycle.[Pubmed:31863859]
J Ethnopharmacol. 2020 Mar 25;250:112493.
ETHNOPHARMACOLOGICAL RELEVANCE: Lindernia crustacea (L.) F.Muell. (Scrophulariaceae) was selected for phytochemical investigation owing to its traditional use against human herpes virus infection and its anti-Epstein-Barr virus (EBV) effect. AIMS OF THE STUDY: The present study focused on the phytochemical investigation of L. crustacea including the isolation and structure determination of its biologically active compounds. Compounds with anti-EBV effects were also investigated. MATERIALS AND METHODS: The EtOH extract of L. crustacea was subsequently partitioned using different solvents. The EtOAc fraction was subjected to several chromatographic methods to obtain pure compounds. The structures of all isolates were established by spectroscopic analysis and compared with previously reported physical data. The anti-EBV effect was evaluated in an EBV-containing Burkitt's lymphoma cell line (P3HR1) to study the expression of EBV lytic proteins. RESULTS: Thirty-three compounds, including one diterpene (1), four anthraquinones (2-5), two ionones (6 and 7), fourteen phenylpropanoid glycosides (8-21), five flavonoids (22-26), one lignan glycoside (27), one phenethyl alcohol glycoside (28), one phenylpropene glycoside (29), one glucosyl glycerol derivative (30), one furanone (31), and two cinnamic acid derivatives (32 and 33), were isolated from the ethanolic extract of the plant. All isolated compounds were obtained for the first time from Lindernia sp. The evaluation of the anti-EBV activity of L. crustacea crude extract, partitioned fractions, and constituents was performed for the first time. Phytol (1), aloe-emodin (2), byzantionoside B (7), a mixture of trans-martynoside (8) and cis-Martynoside (9), a mixture of trans-isomartynoside (10) and cis-isomartynoside (11), luteolin-7-O-beta-D-glucopyranoside (24), and apigenin-7-O-[beta-D-apiofuranosyl (1-->6)-beta-D-glucopyranoside] (25) exhibited significant inhibitory effects on the EBV lytic cycle at 20 mug/mL in the immunoblot analysis. On the other hand, (6R,7E,9R)-3-oxo-alpha-ionol-beta-D-glucopyranoside (6) and a mixture of trans-dolichandroside A (12) and cis-dolichandroside A (13) showed moderate anti-EBV activity at 20 mug/mL. CONCLUSIONS: L. crustacea and its active isolates could be developed as potential candidates against EBV. Our findings provide scientific evidence for the traditional use of L. crustacea for its antiviral effects.
Chemical constituents and HRESI-MS analysis of an Algerian endemic plant - Verbascum atlanticum batt. - extracts and their antioxidant activity.[Pubmed:31009247]
Nat Prod Res. 2019 Apr 22:1-5.
This is the first report on the phytochemistry and antioxidant activity of ethyl acetate and n- butanol extracts from an Algerian endemic plant Verbascum atlanticum Batt. (Scrophulariaceae). Both extracts were subjected to a phytochemical study by semi-preparative HPLC, which led to the isolation and identification of nine compounds: methyl linolenate (1), methyl linoleate (2), Phytol-1(3), Martynoside (4), Isomartynoside (5), cis-Martynoside (6), Ilwensisaponin C (7), Ilwensisaponin B (8), Ilwensisaponin A (9). In addition, the fractions from both extracts were analysed by LC-UV-MS and HRESI-MS. This later revealed the presence of eight other metabolites by using a comparison with known microbial metabolites data. Finally, both extracts were estimated for their phenolic and flavonoid contents as well as the evaluation of their antioxidant activity using five different assays DPPH, CUPRAC, reducing power, beta-carotene bleaching and superoxide DMSO alkaline. The results showed that the ethyl acetate extract had the most antioxidant effect.
Phenylpropanoid glycosides from Penstemon serrulatus.[Pubmed:9917298]
J Nat Prod. 1999 Jan;62(1):127-9.
Two new phenylpropanoid glycosides named cis-Martynoside (1) and cis-leucosceptoside A (3) were recognized in cell suspension cultures of Penstemon serrulatus Menz. The structures of these compounds were determined on the basis of 1H NMR spectral data.